5min read
PREVIOUS ARTICLE Oil falls 3% as Trump urges OP... NEXT ARTICLE Copper price approaches eight-...

APX – APPEN LIMITED – up 21.74 per cent, or $4.09, to $22.90

The Sydney-based producer of human-annotated datasets for machine learning said last year its underlying profit after tax increased 192 per cent, to $49 million. Its shares are at an all-time high, up more than 75 per cent on the year and 45 times its January 2015 initial offering.

GTN – GTN LTD – up 19.47 per cent, or 18.5 cents, to $1.135

The broadcast media advertising platform said its half-year profits had fallen 22 per cent amid tough conditions from its Australian operations, but announced a share buy-back of 10 per cent of its shares.

APT – AFTERPAY TOUCH – up 19.19 per cent, or $3.30 cents, to $20.50

Z1P – ZIP CO LTD – up 3.82 per cent, or 5.5 cents, to $1.495

Buy now, pay later services Afterpay and Zip led tech stocks as regulatory clouds cleared in the wake of Friday’s findings from the Senate Economics Committee.

GSW – GETSWIFT LIMITED – down 31.82 per cent, or 14 cents, to 30 cents

ASIC has started a civil penalty proceedings against the logistics software delivery company and two of its directors for allegedly making misleading announcements relating to agreements with clients. GetSwift denies the allegations.

G8 EDUCATION – down 11.02 per cent, or 40 cents, to $3.23

Australia’s largest childcare and early education provider reported full-year profit fell 11 per cent to $71.8 million.

BXB – BRAMBLES – up 2.84 per cent, or 33 cents, to $11.93

The global logistics company announced the sale of plastic containers business IFCO for $2.7 billion, and said it would return the bulk of the proceeds from the sale to shareholders.

BSL – BLUESCOPE STEEL – up 6.32 per cent, or 78 cents, to $13.13

The steelmaker has lifted first-half profit 42 per cent to $624.3 million, and beat its earnings guidance for what its managing director calls the company’s best half on record.

AC8 – AUSCANN GROUP – up 4.94 per cent, or 2 cents, to 42.5 cents

The Perth-based medical cannabis company has hired an experienced Teva Pharmaceuticals executive as its new chief executive.